Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

被引：0
|
作者：
Qu, Chen [1 ]
Zheng, Dandan [1 ]
Li, Sai [2 ]
Lidofsky, Anna [3 ]
Jiang, Yuchuan [1 ]
He, Lu [1 ]
Yuan, Hui [1 ]
Chen, Xijun [1 ]
Hu, Qiaoting [4 ]
Luo, Xiaojun [4 ]
Zhou, Yuchen [1 ]
Lin, Wenyu [3 ]
Chung, Raymond T. [3 ]
Hong, Jian [1 ,3 ]
机构：
[1] Southern Med Univ, Dept Abdominal Surg, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Dept Pharm, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA USA
[4] Southern Med Univ, Dept Expt Res, Ctr Canc, Guangzhou, Guangdong, Peoples R China
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
240
引用
收藏
页码：136A / 137A
页数：2
相关论文
共 50 条
  • [41] Bruton's tyrosine kinase as a new therapeutic target
    Uckun, Fatih M.
    Tibbles, Heather E.
    Vassilev, Alexei O.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 624 - 632
  • [42] MERTK receptor tyrosine kinase is a therapeutic target in melanoma
    Schlegel, Jennifer
    Sambade, Maria J.
    Sather, Susan
    Moschos, Stergios J.
    Tan, Aik-Choon
    Winges, Amanda
    DeRyckere, Deborah
    Carson, Craig C.
    Trenthath, Dimitri G.
    Tentler, John J.
    Eckhardt, S. Gail
    Kuan, Pei-Fen
    Hamilton, Ronald L.
    Duncan, Lyn M.
    Miller, C. Ryan
    Nikolaishvili-Feinberg, Nana
    Midkiff, Bentley R.
    Liu, Jing
    Zhang, Weihe
    Yang, Chao
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    Shields, Janie M.
    Graham, Douglas K.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05): : 2257 - 2267
  • [43] Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels
    Leonhardt, F.
    Zirlik, K.
    Buchner, M.
    Prinz, G.
    Hechinger, A-K
    Gerlach, U. V.
    Fisch, P.
    Schmitt-Graeff, A.
    Reichardt, W.
    Zeiser, R.
    LEUKEMIA, 2012, 26 (07) : 1617 - 1629
  • [44] Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (01): : 18 - 19
  • [45] Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth
    Gururajan, Murali
    Dasu, Trivikram
    Shahidain, Seif
    Jennings, C. Darrell
    Robertson, Darrell A.
    Rangnekar, Vivek M.
    Bondada, Subbarao
    JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 111 - 121
  • [46] Autophagy: A new therapeutic target for liver fibrosis
    Mao, Yu-Qing
    Fan, Xiao-Ming
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (16) : 1982 - 1986
  • [47] Autophagy:A new therapeutic target for liver fibrosis
    Yu-Qing Mao
    Xiao-Ming Fan
    World Journal of Hepatology, 2015, (16) : 1982 - 1986
  • [48] Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels
    F Leonhardt
    K Zirlik
    M Buchner
    G Prinz
    A-K Hechinger
    U V Gerlach
    P Fisch
    A Schmitt-Gräff
    W Reichardt
    R Zeiser
    Leukemia, 2012, 26 : 1617 - 1629
  • [49] Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents
    Kaur, Charanjit
    Thakur, Amandeep
    Liou, Ke-Chi
    Rao, Neralla Vijayakameswara
    Nepali, Kunal
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (09) : 897 - 914
  • [50] Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
    Li, Tianfeng
    Deng, Yi
    Shi, Yu
    Tian, Ruijun
    Chen, Yonglong
    Zou, Lin
    Kazi, Julhash U.
    Ronnstrand, Lars
    Feng, Bo
    Chan, Sun On
    Chan, Wai Yee
    Sun, Jianmin
    Zhao, Hui
    ONCOGENE, 2018, 37 (47) : 6180 - 6194
12345